1) Bejarano V, et al. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum. 2008 ; 59 : 1467-74.
2) Breedvald FC, et al. The PREMIER Study.Arthritis Rheum. 2006 ; 54 : 26-37.
3) Doran MF, et al. Frequency of infection in patients with rheumatoid arthritis compared with controls. Arthritis Rheum. 2002 ; 46 : 2287-93.
4) Gilworth G, et al. Development of a work instability scale for rheumatoid arthritis. Arthritis Rheum (Arthritis Care Res). 2003 ; 49 : 349-54.
5) Goekoop-Ruiterman YPM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt Study). A randomized, controlled trial. Arthritis Rheum. 2005 ; 52 : 3381-90. DOI: 10.1002/art.21405.